Cardiovalve

Developer of a novel transcatheter valve replacement system for mitral and tricuspid valve replacement. This system is designed for transfemoral delivery, avoiding open-heart surgery. Key features include a short profile

placeOr Yehuda, Tel Aviv, Israel calendar_todayFounded 2011 groups47 employees language cardiovalve.com

Innovation

39 patent families (35 granted) — focus: Human necessities, Operations & transport; filing pace slowing. Cited 153,015 times.

YearFilings
20161
20183
201923
202023
202119
202222
202325
202419
202519
20263

Social engagement

Social engagement: 8.2K social following, 8 posts in the last 12 months — around the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%

Recent activity

3 Jun 2026
Event
CSI Frankfurt
1 Jun 2026
Event
VenusP-Valve Scientific Symposium
29 May 2026
Event
CSI congress Frankfurt
Coming soon